Social Burden and Goals of Therapy for Patients with Bronchiectasis
Opinion
Video
A medical professional addresses the social aspects of bronchiectasis, emphasizing patients' embarrassment due to productive coughing in public spaces like grocery stores and churches, as well as the psychological challenges of planning travel and vacations due to the unpredictability of exacerbations, which can lead to social isolation.
Social Burden and Goals of Therapy for Patients with Bronchiectasis
A medical professional addresses the social aspects of bronchiectasis, emphasizing patients' embarrassment due to productive coughing in public spaces like grocery stores and churches, as well as the psychological challenges of planning travel and vacations due to the unpredictability of exacerbations, which can lead to social isolation.
EP: 1.Overview of Bronchiectasis
EP: 2.Prognosis For Patients Diagnosed With Bronchiectasis
EP: 3.Indicators Leading to Bronchiectasis Testing and Diagnosis
EP: 4.Complications Associated With Bronchiectasis
EP: 5.Current Treatment Options For Bronchiectasis
EP: 6.Respiratory and Physical Therapists Contributing to Comprehensive Bronchiectasis Care
EP: 7.Key Areas of Research and Emerging Therapies In Bronchiectasis Treatment
EP: 8.Diagnosing and Understanding the Pathogenesis of Bronchiectasis
EP: 9.Improving Long-Term Outlook: CT Scans and Underdiagnosis of Bronchiectasis
EP: 10.Bronchiectasis Exacerbation Management
EP: 11.Social Burden and Goals of Therapy for Patients with Bronchiectasis
EP: 12.Patient Specific Factors: Guiding Treatment in Bronchiectasis
EP: 13.Individualized Therapy for Specific Infections Associated with Bronchiectasis
EP: 14.Other Challenges With Bronchiectasis and Key Takeaways
EP: 15.Identifying Bronchiectasis: Key Clinical Presentations to Consider
EP: 16.Differentiating Bronchiectasis from COPD and Understanding Exacerbations
EP: 17.Long-Term Impact of Bronchiectasis Exacerbations: Disease Progression, Patient Outcomes, and Economic Burden
EP: 18.Managing Bronchiectasis: Treatment Goals, Outcome Measures, and Clinical Decision Resources
EP: 19.Addressing Knowledge Gaps and Treatment Strategies in Bronchiectasis
EP: 20.Challenges and Future Directions in Bronchiectasis Management
GLP-1s More Effective at Preventing Colorectal Cancer Than Aspirin
January 6th 2026These results were presented during the press briefing ahead of the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium.
Read More
Switching From MA to TM Increases Mental Health Care Use: Angela Liu, PhD, MPH
December 23rd 2025Angela Liu, PhD, MPH, speaks about her study that examined mental health care use by Medicare beneficiaries before and after switching from MA to TM.
Listen
‘Our Responsibility Should Be to Give You the Closest Thing to a Normal Life’
January 2nd 2026Read More
Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care
November 25th 2025Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.
Listen
Top 5 Trending FDA Approvals of 2025
December 31st 2025These pieces highlight several newly approved therapies that expanded treatment options across multiple disease states.
Read More
ICYMI: Highlights From SABCS 2025
December 29th 2025New therapies and individualized care plans for menopausal women highlighted the most-read 2025 SABCS coverage.
Read More
GLP-1s More Effective at Preventing Colorectal Cancer Than Aspirin
January 6th 2026These results were presented during the press briefing ahead of the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium.
Read More
Switching From MA to TM Increases Mental Health Care Use: Angela Liu, PhD, MPH
December 23rd 2025Angela Liu, PhD, MPH, speaks about her study that examined mental health care use by Medicare beneficiaries before and after switching from MA to TM.
Listen
‘Our Responsibility Should Be to Give You the Closest Thing to a Normal Life’
January 2nd 2026Read More
Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care
November 25th 2025Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.
Listen
Top 5 Trending FDA Approvals of 2025
December 31st 2025These pieces highlight several newly approved therapies that expanded treatment options across multiple disease states.
Read More
ICYMI: Highlights From SABCS 2025
December 29th 2025New therapies and individualized care plans for menopausal women highlighted the most-read 2025 SABCS coverage.
Read More